Company intelligence / Profile preview

Lacamas Laboratories

Portland, Oregon, United States

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Lacamas Laboratories manufactures fine chemicals and pharmaceutical intermediates on a large scale for global partners under cGMP guidelines, focusing on process development, scale-up, and custom synthesis. They do not have clinical-stage programs or results, as they are a service provider rather than a drug developer[1][2][3][4][6].

Modalities: Small moleculeFine chemicalsAPIs (Active Pharmaceutical Ingredients)Pharmaceutical intermediates
Industry: Contract Manufacturing Organization

Partnerships

Has partnered with ACMI and the US Department of Defense for domestic chemical production initiatives[3]

Beyond the preview

Go deeper on Lacamas Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lacamas Laboratories.

Explore the full profile